Prohormones and Designer-Steroid 'Supplements' in the Gray Zone
DSHEA, the Andro Era, and the FDA/DEA Crackdowns That Followed
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Marketed as supplements; many are unapproved drugs or scheduled steroids
- WADA
- Many constituents are prohibited S1 Anabolic Agents
Reference only. Not medical advice.
What can go wrong
These products carry doubled risk: legal exposure (many are scheduled steroids despite the 'supplement' label) and health hazard (hepatotoxicity, cardiovascular and endocrine effects of unmonitored, often uncharacterized androgens). Liver injury from designer-steroid supplements is well documented in the hepatology literature. Evidence grade here is low (grade 1-2): efficacy claims are largely unproven and the safety profile of novel analogues is essentially unknown.
This is something to take to a clinician. The Atlas can tell you what is known about prohormones and designer-steroid 'supplements' in the gray zone in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Where DSHEA's permissive supplement regime collided with steroid chemistry. Through the late 1990s and 2000s, products marketed as legal 'prohormones' (androstenedione and analogues) and later overt 'designer steroids' were sold in the supplement aisle. The 2004 Anabolic Steroid Control Act scheduled the first generation; chemists responded with structurally altered analogues not yet listed, the designer-steroid game, which the Designer Anabolic Steroid Control Act of 2014 (DASCA) tried to close by controlling substances by similarity and criminalizing false labeling. FDA and DEA have repeatedly issued warning letters, seizures, and import alerts against spiked muscle-building products.
Sold on supplement shelves as 'natural,' many of these products are unlisted steroids one tweak ahead of the law.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
DSHEA lets supplements reach market without proving safety or efficacy, and bars FDA from pre-market approval, so makers labeled steroid precursors and analogues as 'dietary ingredients.' Each scheduling action removed specific compounds from legality; makers substituted unlisted analogues, exploiting the gap between a fixed list and an open chemical space. DASCA narrowed this by defining anabolic steroids to include substances substantially similar to listed ones and marketed for muscle growth, and by criminalizing labels that hide or misname an anabolic steroid.
The arms race is structural, not incidental
Because the law historically controlled named molecules while chemistry offers near-infinite analogues, a perpetual one-step-ahead market formed: ban a compound, sell its cousin. DASCA's similarity-based definition and expedited temporary-scheduling power were drafted specifically to break this loop, but DEA did not codify the DASCA additions into regulation until 2023, nearly a decade later, leaving long windows in which analogues circulated. The downstream reality is that products promising steroid-like gains 'legally' frequently contain undisclosed scheduled steroids or untested designer compounds with unknown toxicity.
Replacement is not the same as a cycle
Many of these products deliver active androgens at uncontrolled, often supraphysiological levels with no labeling of true potency, so a consumer cannot dose to replacement levels even in principle.
What people get wrong
Often said'Prohormone' supplements are legal and natural
ActuallyMany were scheduled in 2004/2014, and 'designer' analogues are controlled by similarity under DASCA; several contain undisclosed steroids.
Often saidIf a steroid product is sold openly it must be legal
ActuallyOpen sale reflects DSHEA's post-market posture and enforcement lag, not legality; FDA/DEA act after the fact.
Often saidThese products are at least proven to build muscle safely
ActuallyEfficacy is largely unsubstantiated and novel analogues carry unknown, sometimes serious toxicity.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Enabling gap
- DSHEA's no-pre-market-approval supplement regime
- First crackdown
- 2004 Act scheduled androstenedione-type prohormones (DHEA carved out)
- Designer response
- Structurally tweaked analogues sold as 'supplements'
- DASCA 2014
- Similarity-based control; false-labeling crimes; ~22 substances added
- Enforcement tools
- FDA warning letters, recalls, import alerts; DEA scheduling
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Prohormones and Designer-Steroid 'Supplements' in the Gray Zone. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Anabolic Steroid Control Act of 20042004
Scheduled androstenedione-class prohormones sold as supplements
Designer Anabolic Steroid Control Act (DASCA)2014
Similarity-based control and false-labeling crimes targeting analogues
Designer-steroid supplement hepatotoxicity reportsvarious
Case series of liver injury from muscle-building 'supplements' containing undisclosed steroids
DEA codification of DASCA additions2023
Implemented the 2014 list almost a decade after enactment